Search
for
Sort by
Research 271–300 of 408
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Systematic approach to hair loss in women
- Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats
- Alopecia in Association with Malignancy: A Review
- Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia
- An Update on Drug-Induced Pigmentation
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Alopecia associated with quetiapine
- Lessons Learned from the First Decade of Laser-Assisted Drug Delivery
- Hair loss with levetiracetam in five patients with epilepsy
- Isoniazid-induced alopecia
- Psychoactive drugs and skin
- Accelerated Wound Healing Using Nanoparticles
- Prevention of Alopecia in Medical and Interventional Chemotherapy Patients
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- An overview of management of drug-induced hair and nail disorders
- RNA sequence analysis of dermal papilla cells’ regeneration in 3D culture
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Ottawa, Ontario, Canada, February 13–16, 2013
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Diseases of the Hair and Nails
- Tacrolimus in Dermatology
- Scalp Tourniquets for Chemotherapy-Induced Alopecia
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Dermatologic Care of the Transplant Patient
- The Cross-section Trichometer
- Development of a low-cost device for photobiomodulation using 3D printing
- Chemotherapy and Cutaneous Drug Reactions
- Docetaxel-induced Psoriasis